SEATTLE — NanoString Technologies, Inc., a privately held life sciences company marketing a molecular barcoding detection system, today announced that the National Cancer Institute (NCI) is employing its nCounter™ Analysis System at two of its core labs. One system was purchased by the NCI Center for Cancer Research (CCR) through the Institute’s Office of Science […]
Companies develop technology to visualize and map complex biomarker networks Discovery could enable faster drug development at less cost, provide more personalized therapies Extension of molecular pathology research agreement planned NEW YORK & INDIANAPOLIS — Scientists at GE Global Research (NYSE: GE – News), and researchers at Eli Lilly and Company (NYSE: LLY – News) […]
Sets New Standards for Throughput, Data Quality and Ease-of-Use CARLSBAD, Calif. — Applied Biosystems, part of Life Technologies Corporation (NASDAQ:LIFE), today announced the global commercial availability of a new capillary electrophoresis (CE) sequencing system. The 3500 Series Genetic Analyzer builds on Applied Biosystems’ industry-leading CE sequencing systems, with state-of-the-art advancements, setting significant new standards for […]
Hosted by Novartis and Keynoted by Pfizer, the Event Highlighted Caliper’s LabChip(R) Technologies that Improve Drug Discovery Decision Making HOPKINTON, Mass. — Caliper Life Sciences, Inc. (Nasdaq: CALP – News), a leading provider of tools and services for drug discovery and life sciences research, last week held the latest seminar in its “Innovation for Experimentation” […]
SOUTH EASTON, Mass. — Pressure BioSciences, Inc. (Nasdaq:PBIO – News) (“PBI” and the “Company”) today announced that scientists from the University of North Texas Health Science Center at Fort Worth, Texas (“UNTHSC”) reported notable improvements in the yields of DNA from challenging forensic samples — such as human hair and bone samples — when the […]
New equity investment fund to invest in high potential healthcare technology companies; Supports GE’s global Healthymagination initiative, focusing on cost, access and quality. Fairfield, CT, USA – GE (NYSE: GE) announced today the formation of the “GE Healthymagination Fund”, a new equity fund that will make investments in highly promising healthcare technology companies. The fund […]
KNOXVILLE, TN and WOBURN, MA — Protein Discovery, Inc. and New Objective, Inc. today announced that they have entered into a strategic co-marketing and development agreement designed to enable and expand key applications for intact protein analysis using mass spectrometry (“top down” proteomics). The companies intend to co-market their respective product lines focused on “sample […]
GE Healthcare Expands Life Cycle Asset Management Solution with Integration of Asset Disposal Service Chalfont St. Giles, UK – GE Healthcare, a unit of General Electric Company (NYSE: GE), announces a strategic collaboration with GoIndustry DoveBid (GoIDB). The partnership enhances GE Healthcare’s asset disposal capabilities and expands its ability to provide critical business intelligence to […]
TORONTO – MDS Inc. (TSX: MDS – News; NYSE: MDZ – News), a leading provider of products and services to the global life sciences markets, today announced that Company shareholders have approved the sale of its MDS Analytical Technologies business, a leading global supplier of drug discovery and life sciences research tools, to Danaher Corporation […]
Agreement Brings Integrated Fluidic Circuit Technology to Turkish Scientists Specializing in Digital and Real-Time PCR, Genotyping, Single-Cell Gene Expression, Cancer Detection and Absolute Quantification SOUTH SAN FRANCISCO, Calif. & ADANA, Turkey- – Fluidigm Corporation, the inventor of integrated fluidic circuits (IFCs), has appointed Nano Gen Teknolojileri Ltd. as its exclusive distributor for the BioMark™ and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
